Skip to main content
. 2020 Jan 20;2020(1):CD011628. doi: 10.1002/14651858.CD011628.pub2

Comparison 11. Guselkumab 100 mg vs placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Proportion of participants cleared or almost cleared in the short term 1 107 Risk Ratio (M‐H, Random, 95% CI) 1.31 [0.31, 5.57]